Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors

Polish Journal of Pathology

Volumn 56, Issue 1, 2005, Pages 27-35

  Ferenc, Tomasz ^a   Lewiński, Andrzej ^a   Lange, Dariusz ^b   Niewiadomska, Hanna ^a   Sygut, Jacek ^c   Sporny, Stanisław ^a   Jarza̧b, Barbara ^b   Sałacińska Łoś, Elzbieta ^a   Kulig, Andrzej ^d   Włoch, Jan ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c Swietokrzyskie Centrum Onkologii Poland   (Poland)

^d POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; RETINOBLASTOMA PROTEIN;

ADENOMA; ARTICLE; CANCER CELL; CELL CYCLE; GOITER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; RETINOBLASTOMA; STAINING; THYROID CARCINOMA; THYROID TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; CYCLIN D1; GOITER, NODULAR; HUMANS; RETINOBLASTOMA PROTEIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 21144439713     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. WAFI immunohistochcmical expression. Int J Cancer 1997, 74, 171-174.
2. Barnes DM: Cyclin D1 in mammary carcinoma. J Pathol 1997, 181, 267-269.
3. Bartek J, Lukas J, Bartkova J: Perspective: defects in cell cycle control and cancer. J Pathol 1999, 187, 95-99.
4. Björklund S, Almouzni G, Davidson I, Nightingale KP, Weiss K: Global transcription regulators of Eukaryotes. Cell 1999, 96, 759-767.
5. WAFI. Cancer Res 1995, 55, 4536-4539.
6. Cordon-Cardo C, Zhang Z-F, Dalbangi G, Drobnjak M, Charytonowicz E, Hu S-X, Xu H-J, Reuter VE, Benedict W: Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 1997, 57, 1217-1221.
7. Cordon-Cardo C: Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995, 147, 545-560.
8. De Jong JS, Van Diest PJ, Michalides R, Baak JP: Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. J Clin Patol: Mol Pathol 1999, 52, 78-83.
9. Donehower LA, Bradley A: The tumor suppressor p53. Acta Biochim Biophys 1993, 1155, 181-205.
10. Dong Y, Walsh MD McGuckin MA, Cummings MC, Gabrielli BG, Wright GR, Hurst T, Khoo SK, Parson PG: Reduced expression of retinoblastoma gene product (pRb) and high expression of p53 are associated with poor prognosis in ovarian cancer. Int J Cancer 1997, 74, 407-415.
11. INK4A in ovarian cancer is associated with progression and unfavourable prognosis. Int J Cancer 1997, 74, 57-63.
12. Donnellan R, Chetty R: Cyclin D1 and human neoplasia. J Clin Pathol: Mol Pathol 1998, 51, 1-7.
13. Fernandez PL, Jares P, Rey MJ, Campo E, Cardesa A: Cell cycle regulators their abnormalities in breast cancer. J Clin Pathol: Mol Pathol 1998, 51, 305-309.
14. Figge J, Bakst G, Weisheit D, Solis O, Ross JS: Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique. Am J Pathol 1991, 139, 1213-1219.
15. INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res. 1995, 55, 6006-6011.
16. Gillet CE, Barnes DM: Cell cycle. J Clin Pathol: Mol Pathol 1998, 51, 310-316.
17. Gillett CE, Lee AHS, Milis RR, Barnes DA: Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 1998, 184, 396-400.
18. Goodrich DW, Lee W-H: Molecular characterization of the retinoblastoma susceptibility gene. Acta Biochim Biophys 1993, 1155, 43-61.
19. nd ed. Berlin, Germany, Springer-Verlag 1988.
20. Hedinger C, Williams ED, Sobin LH: The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer Res 1989, 63, 908-911.
21. Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R: Retinoblastoma protein expression in lung cancer: an immunohistochemical analysis. Oncology 1994, 51, 544-551.
22. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of human cyclins as an oncogene. Proc Natl Acad Sci USA 1994, 91, 709-713.
23. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995, 86, 841-854.
24. Holm R, Tanum G, Karlsen F, Nesland JM: Prevalence and physical state of human papillomavirus DNA in anal carcinomas. Mod Pathol 1994, 7, 449-453.
25. Hsi ED, Zukerberg LR, Yang WI, Arnold A: Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 1996, 81, 1736-1739.
26. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29, 577-580.
27. Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A, Ogoshi S: Cyclin D1 overexpression related to retinoblastoma protein expression as prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 1998, 77, 92-97.
28. Jares P, Rey MJ, Fernandez PL, Campo E, Nadal A, Munoz M, Mallofre C, Muntane J, Nayach I, Estape J, Cardesa A: Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J Pathol 1997, 182, 160-166.
29. INK4 gene mediated by an adenovirus vector. Cancer Res 1995, 55, 3250-3253.
30. Koreth J, Bakkenist CJ, McGee JO'D: Chromosomes, 11q and cancer: a review. J Pathol 1999, 187, 28-38.
31. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H, Fukumoto M: Cyclin D1 gene amplifications is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 1997, 74, 576-581.
32. Lai S, Benedict WF, Silver SA, El-Naggar AK: Loss of retinoblastoma gene function and heterozygosity at the Rb locus in renal cortical neoplasms. Hum Pathol 1997, 28, 693-697.
33. Lazzereschi D, Sambuco L, Carnovale Scalzo C, Rannieri A, Mincione G, Nardi F, Coletta G: Cyclin D1 and cyclin E expression in malignant thyroid cells and human thyroid carcinomas. Int J Cancer 1998, 76, 806-811.
34. kipl: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999, 154, 313-323.
35. Lukas J, Müller H, Bartkova J, Spilkovsky D, Kjerulff AA, Jansen-Durr P, Straus M, Bartek J: DNA tumor virus oncoproteins and retino-blastoma gene mutations share the ability to relative the cells requirement for cyclin D1 function in G1. J Cell Biol 1994, 125, 625-638.
36. Lundberg AS, Weinberg RA: Control of the cell cycle and apoptosis. Eur J Cancer 1999, 35, 531-539.
37. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Gaeta P, La Rocca R, Merlo G, Chella A, Angeletti CA, Della Palma P, Bevilacqua G: Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. Int J Cancer 1998, 75, 187-192.
38. Michalides RJ, Hageman P, Van Tinteren H, Houben L, Wientjens E, Klompmaker R, Peterse J: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996, 73, 728-734.
39. Michalides RJ: Prognosis for G1 cell-cycle regulators: useful for predicting course of disease and for assessment of therapy in cancer. J Pathol 1999, 188, 341-343.
40. Michalides RJ: Cell cycle regulators: mechanisms and their role in actiology, prognosis, and treatment of cancer. J Clin Pathol 1999, 52, 555-568.
41. Morgan DO: Principles of CDK regulation. Nature 1995, 374, 131-134.
42. Motokura T, Arnold A: Cyclins and oneogenesis. Biochim Biophys Acta 1993, 1155, 63-78.
43. Murray AW: Recycling the cell cycle: cyclins revisited. Cell 2004, 116, 221-234.
44. Müller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994, 91, 2945-2949.
45. Nabori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994, 368, 753-756.
46. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattor T: Overexpression and localization of cyclin D1 mRNA and antigen in esophagcal cancer. Am J Pathol 1995, 146, 1161-1169.
47. Nakashima M, Meirmanov S, Naruke Y, Kondo H, Saenko V, Rogounovitch T, Shimizu-Yoshida Y, Takamura N, Namba H, Ito M, Abrosimov A, Leshnikov E, Roumiantsev P, Tsyb A, Yamashita S, Sekine I: Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area, its correlation with Pin1 and aberrant β-catenin expression. J Pathol 2004, 202, 446-455.
48. Nikaido T, Li SF, Shiozawa T, Fujii S: Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer 1996, 78, 1248-1253.
49. Prives C, Hall PA: The p53 pathway. J Pathol 1999, 187, 112-126.
50. Ren S, Rollins BJ: Cyclin c/cdk3 promotes Rb-dependent G0 exit. Cell 2004, 117, 239-251.
51. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366, 701-704.
52. Sherr CJ: Principles of tumor suppression. Cell 2004, 116, 235-246.
53. Tanum G, Holm R: Anal carcinoma: a clinical approach to p53 and Rb gene proteins. Oncology 1996, 53, 369-373.
54. INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer 1997, 74, 508-512.
55. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995, 81, 323-330.
56. White RJ: Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control? TIBS 1997, 22, 77-80.
57. Wynford-Thomas D: Cellular senescence and cancer. J Pathol 1999, 187, 100-111.
58. Yee AS, Shih HH, Tevosian SG: New perspectives on retinoblastoma family functions in differentiation. Front Biosci 1998, 3, D532-D547.
59. Zou M, Shi Y, Farid NR: Frequent inactivation of the retinoblastoma gene in human thyroid carcinoma. Endocrine J 1994, 2, 193-198.